XML 29 R17.htm IDEA: XBRL DOCUMENT
v3.21.2

Stock-based Compensation | 9 Months Ended
--- | ---
Sep. 30, 2021
Share-based Payment Arrangement [Abstract] |
Stock-based Compensation | Stock-Based Compensation Stock-based compensation expense for stock options and RSUs is reflected in the condensed consolidated statements of operations and comprehensive loss as follows (in thousands):
| Three months ended September 30, |  | Nine months ended September 30,
| 2021 |  | 2020 |  | 2021 |  | 2020
General and administrative | $ | 840 |  |  | $ | 101 |  |  | $ | 2,957 |  |  | $ | 248 |
Research and development | 507 |  |  | 25 |  |  | 1,318 |  |  | 249 |
Total | $ | 1,347 |  |  | $ | 126 |  |  | $ | 4,275 |  |  | $ | 497 |
Stock-based compensation expense during the three and nine months ended September 30, 2021 included $41.3 thousand and $1.1 million of expense related to stock options with performance-based vesting conditions, respectively. No stock-based compensation expense during the three and nine months ended September 30, 2020 was related to stock options with performance-based vesting conditions. As of September 30, 2021, the Company had $13.9 million of unrecognized stock-based compensation expense related to stock options and RSUs outstanding. This expense is expected to be recognized over a weighted-average period of 2.2 years as of September 30, 2021. Equity Plans The Company maintains two equity compensation plans, the 2014 Ocugen OpCo, Inc. Stock Option Plan (the “2014 Plan”) and the Ocugen, Inc. 2019 Equity Incentive Plan (the “2019 Plan”, collectively with the 2014 Plan, the "Plans"). As of September 30, 2021, the 2014 Plan and 2019 Plan authorize for the granting of up to 0.8 million and 11.5 million equity awards in respect to the Company's common stock, respectively. In addition to stock options and RSUs granted under the Plans, the Company has granted certain stock options and RSUs as material inducements to employment in accordance with Nasdaq Listing Rule 5635(c)(4), which were granted outside of the Plans. Options to Purchase Common Stock The following table summarizes the stock option activity:
| Number of Shares |  | Weighted-Average Exercise Price |  | Weighted-Average Remaining Contractual Life (years) |  | Aggregate Intrinsic Value (in thousands)
Options outstanding at December 31, 2020 | 4,224,433 |  |  | $ | 0.84 |  |  | 8.9 |  | $ | 5,496 |
Granted | 7,469,300 |  |  | $ | 3.33 |  |  |  |  | $ | — |
Exercised | (901,250) |  |  | $ | 0.73 |  |  |  |  | $ | 8,042 |
Forfeited | (274,220) |  |  | $ | 2.96 |  |  |  |  | $ | 1,146 |
Options outstanding at September 30, 2021 | 10,518,263 |  |  | $ | 2.56 |  |  | 9.0 |  | $ | 49,552 |
Options exercisable at September 30, 2021 | 991,429 |  |  | $ | 1.71 |  |  | 7.8 |  | $ | 5,629 |
Stock options not yet exercisable as of September 30, 2021 includes 1.5 million stock options with performance-based vesting conditions. There were no stock options with performance-based vesting conditions as of December 31, 2020. The weighted-average grant date fair values of stock options granted during the three and nine months ended September 30, 2021 were $5.97 and $2.77, respectively. The weighted-average grant date fair value of stock options granted during both the three and nine months ended September 30, 2020 was $0.34 per share. The total fair values of stock options vested during the three and nine months ended September 30, 2021 were $0.1 million and $0.7 million, respectively. The total fair values of stock options vested during the three and nine months ended September 30, 2020 were $0.1 million and $0.3 million, respectively. RSUs The following table summarizes the RSU activity:
| Number of Shares |  | Weighted- Average Grant-Date Fair Value |  | Aggregate Intrinsic Value (in thousands) |  |  |  |
RSUs outstanding at December 31, 2020 | — |  |  | $ | — |  |  | $ | — |  |  |  |  |
Granted | 179,951 |  |  | $ | 6.69 |  |  | $ | 1,280 |  |  |  |  |
Forfeited | (900) |  |  | $ | 8.75 |  |  | $ | 6 |  |  |  |  |
RSUs outstanding at September 30, 2021 | 179,051 |  |  | $ | 6.68 |  |  | $ | 1,286 |  |  |  |  |

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration